Worth Asset Management LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 38.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 873 shares of the healthcare conglomerate’s stock after selling 535 shares during the period. Worth Asset Management LLC’s holdings in UnitedHealth Group were worth $442,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. Lone Pine Capital LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $480,903,000. Dimensional Fund Advisors LP boosted its holdings in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Accredited Investors Inc. lifted its position in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares during the period. Finally, Raymond James & Associates grew its holdings in shares of UnitedHealth Group by 33.1% in the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after acquiring an additional 587,088 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have weighed in on UNH. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Barclays increased their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday, November 27th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $627.58.
UnitedHealth Group Trading Up 1.0 %
NYSE:UNH traded up $5.17 on Wednesday, hitting $519.42. 1,400,908 shares of the stock were exchanged, compared to its average volume of 3,382,798. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market cap of $478.01 billion, a PE ratio of 33.84, a PEG ratio of 1.53 and a beta of 0.62. The stock has a fifty day moving average of $557.79 and a 200-day moving average of $561.72.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $6.56 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How to Invest in Blue Chip Stocks
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is the MACD Indicator and How to Use it in Your Trading
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.